However, identification of infants with an inconclusive diagnosis after a positive NBS result—termed cystic fibrosis transmembrane conductance regulator (CFTR)-related metabolic syndrome or CF Screen Positive Inconclusive Diagnosis (CRMS/CFSPID) is an increasingly recognized outcome [6]. This evidence concerns the gene CFTR and metabolic syndrome.